Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-25

Clinical Trial Update: Perioperative Salivary Alpha-amylase as a Predictor of Delirium After Lower Extremity Vascular Bypass Surgery

View source ↗

Summary

A completed clinical trial evaluated whether perioperative salivary alpha-amylase can predict delirium after lower-extremity vascular bypass surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Tanta University | Conditions: Salivary Alpha-amylase, Delirium | Status: COMPLETED